SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Current Liabilities |
|---|---|
| Mar2026 | - |
| Mar2025 | - |
| Mar2024 | - |
| Mar2020 | - |
| Mar2019 | - |
How is Current Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | - | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2020 | - | 0 | |
| Mar2019 | - | - | |
Compare Current Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹858.8 Cr | -5% | 2.4% | 31.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -5% |
2.4% |
31.9% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses